The WHO 2016 guidelines recommend providing lifelong ART to all HIV patients regardless of CD4 cell count but the monitoring of drug resistant HIV-1 is still a challenge to control the HIV/AIDS epidemic. The gene discussed is CD4; the disease is AIDS.